0001415889-23-015898.txt : 20231205 0001415889-23-015898.hdr.sgml : 20231205 20231205182620 ACCESSION NUMBER: 0001415889-23-015898 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231127 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scott John K Jr. CENTRAL INDEX KEY: 0001753763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 231467972 MAIL ADDRESS: STREET 1: 30 BLUE HERON DR. CITY: GREENWOOD VILLAGE STATE: CO ZIP: 80121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 form4-12052023_111210.xml X0508 4 2023-11-27 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001753763 Scott John K Jr. 4995 BRADENTON AVE SUITE 240 DUBLIN OH 43017 true false true false 0 Series G Redeemable Preferred Stock 2023-11-27 4 J 0 2270 D 0 D Series I Convertible Preferred Stock 0.16 2023-11-27 4 J 0 2400 1000 D Common Stock 15000000 0 D Series J Convertible Preffered Stock 0.104 2023-11-27 4 J 0 64289 100 A Common Stock 61816346 64289 D Navidea entered into a Loan and Exchange Agreement with the Reporting Person, pursuant to which he surrendered 2,270 shares of Series G Preferred Stock, par value $.001 per share plus accrued and unpaid dividends thereon, and 2,400 shares of Series I Preferred Stock, par value $.001 per share, and other consideration, in exchange for 64,289 shares of Series J Preferred Stock, par value $.001. Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date. Exhibit 24: John K. Scott, Jr. Power of Attorney Gioia Gentile on behalf of John K. Scott, Jr., by power of attorney 2023-12-05 EX-24 2 ex24-12052023_111210.htm ex24-12052023_111210.htm


POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Craig Dais, Samantha Monson, and Gioia Gentile, signing singly, the undersigned’s true and lawful attorney-in-fact for the limited purpose to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as a director of Navidea Biopharmaceuticals, Inc. (the “Company”), a Form ID, Forms 3, 4, and 5 and any other documents necessary to facilitate the filing of reports in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (collectively, the “Exchange Act”);

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID or Forms 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.


This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5 day of December, 2023.




/s/ John K. Scott, Jr.

Signature


Print Name  John K. Scott, Jr.




4877-0872-5397, v. 1